January 6, 2021 by Chain Drug Review
Alliance Healthcare, AmerisourceBergen Corp and Walgreens Boots Alliance, Ornella Barra, Stefano Pessina, Steven Collis
Business, Leading Headlines, Pharmacy, Retail News

VALLEY FORGE, Pa. — AmerisourceBergen Corp and Walgreens Boots Alliance (WBA) announced on Wednesday strategic agreements under which AmerisourceBergen will acquire the majority of WBA’s Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock. Walgreens’ unit, Alliance Healthcare is one of the largest
September 12, 2018 by Chain Drug Review
AmerisourceBergen, James Cleary, Steven Collis, Tim Guttman
Leading Headlines, Pharmacy, Retail News

VALLEY FORGE, Pa. — AmerisourceBergen Corporation announced that Tim Guttman, executive vice president and chief financial officer, has decided to retire from the company. James Cleary, executive vice president and group president, Global Commercialization Services and Animal Health, will succeed Guttman as executive vice president and chief financial officer. Guttman will step down as chief financial officer
February 13, 2018 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Stefano Pessina, Steven Collis, Walgreens Boots Alliance, Walgreens Boots Alliance Development, WBA, WBAD
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) is in negotiations to acquire drug distributor AmerisourceBergen Corp., according to published reports. Representatives of WBA executive vice chairman and chief executive officer Stefano Pessina made “a high-level outreach” to representatives of AmerisourceBergen chairman and CEO Steven Collis several weeks ago, The Wall Street Journal reported, citing people familiar
December 7, 2017 by Chain Drug Review
AmerisourceBergen, opioid abuse, opioid diversion, opioid epidemic, Steven Collis, Walgreens
Leading Headlines, Pharmacy, Supplier News

VALLEY FORGE, Pa. — AmerisourceBergen has ramped up its efforts to thwart opioid diversion and abuse. The pharmaceutical distributor on Thursday announced ongoing operational commitments to prevent opioid abuse and abuse in line with its initiatives to protect the supply chain. AmerisourceBergen said it will continue to use and enhance a sophisticated set of algorithms
November 20, 2017 by Chain Drug Review
AmerisourceBergen, Arete Pharmacy Network, Dale Smith, H.D. Smith, Robert Mauch, Steven Collis, Triplefin, Valley Wholesale Drug
Business, Featured Articles, Leading Headlines, Supplier News

VALLEY FORGE, Pa. — AmerisourceBergen Corp. plans to acquire fellow pharmaceutical distributor H.D. Smith for $815 million in cash. The companies said late Monday that the transaction, pending regulatory review and other closing conditions, is expected to close in early 2018. Springfield, Ill.-based H. D. Smith, the nation’s largest independent wholesaler, also operates CompleteCare Pharmacy,
June 19, 2017 by Chain Drug Review
AmerisourceBergen, AmerisourceBergen Drug Corp., Gina Clark, James Cleary, James Frary, John Chou, MWI Veterinary Supply, Peyton Howell, pharmaceutical distribution, Robert Mauch, Steven Collis
Business, Featured Articles, Leading Headlines, Pharmacy, Supplier News

VALLEY FORGE, Pa. — AmerisourceBergen Corp. said it has reorganized its operating model and leadership to meet customer needs “in a more seamless and unified way.” The pharmaceutical distributor announced Monday that its customer-facing offerings are now aligned under two groups: Pharmaceutical Distribution and Strategic Global Sourcing, and Global Commercialization Services and Animal Health. The
May 16, 2016 by Geoff Walden and Chain Drug Review
AmerisourceBergen, AmerisourceBergen Drug Corp., Bob Mauch, Brian Nightengale, Dave Neu, Good Neighbor Pharmacy, Steven Collis, Xcenda
2016, Issue 05-16-2016, Issues, News
CONSHOHOCKEN, Pa. — Brian Nightengale has succeeded Dave Neu as president of AmerisourceBergen Corp.’s Good Neighbor Pharmacy. Neu, who has also been executive vice president of retail strategy at AmerisourceBergen, will retire this summer after more than three decades with the company. Nightengale had been president of Xcenda, AmeriscourceBergen’s health economics and outcomes consultancy. He
May 16, 2016 by Chain Drug Review
AmerisourceBergen, pharmaceutical distribution, Steven Collis, Walgreens Boots Alliance
2016, Issue 05-16-2016, Issues, News
VALLEY FORGE, Pa. — AmerisourceBergen announced earlier this month that it has extended the term of its strategic, long-term relationship with Walgreens Boots Alliance Inc. (WBA) for an additional three years. The move extends the pharmaceutical distribution contract and the Walgreens Boots Alliance Development relationship to 2026. The extension includes an enhanced commitment from WBA
May 5, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Steven Collis, Walgreens, Walgreens Boots Alliance, Walgreens Boots Alliance Development, WBA, WBAD
Business, Featured Articles, Leading Headlines, Supplier News

VALLEY FORGE, Pa. — AmerisourceBergen Corp. has extended its strategic partnership with Walgreens Boots Alliance (WBA) Inc. for another three years. AmerisourceBergen said Thursday that its drug distribution contract with WBA and relationship with Walgreens Boots Alliance Development (WBAD) have been lengthened to 2026. AmerisourceBergen and then-merger partners Walgreen Co. and Alliance Boots had announced
April 22, 2016 by Chain Drug Review
ABDC, AmerisourceBergen, AmerisourceBergen Drug Corp., Brian Nightengale, David Neu, Good Neighbor Pharmacy, Robert Mauch, Steven Collis, Xcenda
Featured Articles, Leading Headlines, Pharmacy, Retail News

CONSHOHOCKEN, Pa. — David Neu, executive vice president of retail strategy at AmerisourceBergen Corp. and president of its Good Neighbor Pharmacy network, plans to retire this summer. AmerisourceBergen said Friday that Brian Nightengale, president of company subsidiary Xcenda, a health economics and outcomes consultancy, will take over as Good Neighbor Pharmacy president effective immediately. The
March 18, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Ornella Barra, Steven Collis, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — As part of a long-term partnership announced three years ago, Walgreens Boots Alliance (WBA) is enlarging its equity stake in AmerisourceBergen. WBA said Friday that it has exercised warrants to buy more than 22,696,912 shares of AmerisourceBergen common stock for about $1.17 billion. The transaction was funded with cash on hand, and
March 4, 2016 by Chain Drug Review
AmerisourceBergen, Richard Gozon, Steven Collis
Business, Leading Headlines, Supplier News

PHILADELPHIA — AmerisourceBergen Corp. president and chief executive officer of Steven Collis has taken the reins as chairman. Collis takes over from Richard Gozon, who has retired. The planned succession, announced in November, transpired at the close of AmerisourceBergen’s annual shareholders meeting Thursday in Philadelphia. Collis has served as a director of the pharmaceutical distributor
November 18, 2015 by Chain Drug Review
AmerisourceBergen, Jane Henney, Richard Gozon, Steven Collis
Business, Leading Headlines, Supplier News

VALLEY FORGE, Pa. — Steven Collis, president and chief executive officer of AmerisourceBergen Corp., has been named to succeed Richard Gozon as chairman. The company said Wednesday that Collis is slated to become chairman upon Gozon’s retirement at AmerisourceBergen’s annual shareholders meeting on March 3, 2016. Also at the meeting, current board member Jane Henney,
October 6, 2015 by Chain Drug Review
AmerisourceBergen, AmerisourceBergen Drug Corp., compounded sterile preparations, PharMEDium, Steven Collis, William Spalding
Leading Headlines, Pharmacy, Supplier News

VALLEY FORGE, Pa. — AmerisourceBergen Corp. plans to acquire PharMEDium Healthcare Holdings, Inc., a national provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals, in a $2.575 billion cash deal. AmerisourceBergen said Tuesday that PharMEDium, which is being purchased from private investment firm Clayton, Dubilier & Rice, is the leading provider of customized outsourced